Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...

Results from a new clinical trial led by Wake Forest University School of Medicine and Atrium Health Levine Cancer show that ...

Sickle cell anemia (HbSS) is the homozygous dominant variant and the most common and severe form of the disease. Whereas patients who only inherited one gene encoding for abnormal HbS and a different ...

In the SURPASS-ET trial, ropeginterferon alfa-2b outperformed anagrelide for high-risk essential thrombocythemia patients ...

A nurse at Mulago conducts a review on a sickle cell patient. The World Sickle Cell Awareness Day is observed annually with the goal of increasing public knowledge and a understanding of the disease, ...

Newborn screening will now be mandatory at birth, and children diagnosed with the disease will be followed up to manage ...

The Focus on Sickle Cell Foundation (FoSCel) has called for greater awareness and proactive care for people living with ...

Focus on Sickle Cell Foundation (FoSCel) has called for increased awareness and proactive care for people living with sickle cell disease during its Sickle Cell Fun Fair at Achimota Mall on Saturday, ...

Zydus receives US FDA Orphan Drug Designation for desidustat to treat sickle cell disease: Our Bureau, Mumbai Friday, February 6, 2026, 16:30 Hrs [IST] Zydus, a leading, discovery ...

Zydus Lifesciences Limited on Wednesday announced that the United States Food and Drug Administration (USFDA) has granted ...

New Patient Voice Dynamix™ research highlights that even with patients’ high awareness of options and active engagement in their care, systemic barriers and personal limitations from ongoing severe ...

When asked to picture the ideal cure for sickle-cell disease, molecular biologist Stefano Rivella, a researcher at Children’s Hospital of Philadelphia (CHOP), Pennsylvania, didn’t gaze into the ...